The increase in cAMP and cGMP levels in the oestrogenized rat hypophysis
Jazyk angličtina Země Česko Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
1337470
Knihovny.cz E-zdroje
- MeSH
- AMP cyklický biosyntéza MeSH
- estradiol farmakologie MeSH
- guanosinmonofosfát cyklický biosyntéza MeSH
- hypertrofie chemicky indukované MeSH
- hypofýza účinky léků metabolismus patologie MeSH
- krysa rodu Rattus MeSH
- nitroprusid farmakologie MeSH
- potkani Wistar MeSH
- prolaktin krev MeSH
- velikost orgánu MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- AMP cyklický MeSH
- estradiol MeSH
- guanosinmonofosfát cyklický MeSH
- nitroprusid MeSH
- prolaktin MeSH
Male and female rats were given oestradiol benzoate (1 mg s.c. twice a week for 3 weeks) and/or sodium nitroprusside (SN), a donor of nitric oxide (NO), which was administered in their food in amounts of 0.2 or 0.6 mg/rat/day. Neither oestradiol-induced hypertrophy of the hypophysis, nor the serum prolactin (PRL) level, was affected by the simultaneous administration of SN. The PRL content of the hypophysis rose after oestradiol in the males, but the increase was again uninfluenced by the simultaneous administration of SN and the cAMP content of the hypophysis--raised after oestradiol--was likewise unaffected. The amount of cGMP in the hypophysis after oestradiol rose only in males. Both the serum and the hypophyseal prolactin level were found to be correlated to the cAMP and the cGMP content of the hypophysis. It was found that the simultaneous administration of SN together with oestradiol slightly reduced the increase in the cGMP content of the hypophysis elicited with oestradiol treatment only.
In vivo antiestrogenic activity of mifepristone in the rat